SCHEMBL4362602

SCHEMBL4362602

CCOc1nc2cccnc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.50
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDE5A O76074 1/20 0.38
POLB P06746 3/20 0.37
CBFB Q13951 1/20 0.37
GRM5 P41594 3/20 0.36
ELANE P08246 1/20 0.36
AXL P30530 1/20 0.35
NUDT1 P36639 1/20 0.35
TLR8 Q9NR97 1/20 0.35
TP53 P04637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23122581 0.82 CCNB2 (0.43) ALDH1A1PDE5AGRM5AXLNUDT1
SCHEMBL2675687 0.77 DDAH1 (0.56) KMT2AMEN1ALDH1A1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL28081465 0.75 DDAH1 (0.55) KMT2AMEN1ALDH1A1SMN1; SMN2TP53
SCHEMBL4361327 0.75 DDAH1 (0.55) ALDH1A1SMN1; SMN2POLBAXLNUDT1
SCHEMBL29745294 0.74 PDE5A (0.60) KMT2AALDH1A1SMN1; SMN2PDE5ANUDT1
SCHEMBL10696479 0.74 PDE5A (0.60) KMT2AALDH1A1SMN1; SMN2PDE5ANUDT1
SCHEMBL5315369 0.73 DAO (0.37) ALDH1A1SMN1; SMN2AXLNUDT1TP53
SCHEMBL10514181 0.73 MAPT (0.37) ALDH1A1SMN1; SMN2POLBMAPT
SCHEMBL9853629 0.72 KDM4C (0.48) KDM4CSMN1; SMN2POLBKDM4E
SCHEMBL279584 0.72 PARP1 (0.44) ALDH1A1SMN1; SMN2AXLNUDT1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1988091-B1 TRICYCLIC COMPOUNDS KYOWA HAKKO KIRIN CO LTD (JP) 2015-06-10 EP disclosed
US-8242151-B2 Tricyclic compounds KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-08-14 US disclosed
US-20090176760-A1 TRICYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-07-09 US disclosed
EP-1988091-A1 TRICYCLIC COMPOUNDS Kyowa Hakko Kogyo Co., Ltd (JP) 2008-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176760-A1 TRICYCLIC COMPOUNDS PPARG, PPARD, PPARA KDM4C 1453/4885KMT2A 1525/4885MEN1 4772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.